Ezra Y. Yacob - 10 Mar 2023 Form 4 Insider Report for EOG RESOURCES INC (EOG)

Role
Chairman & CEO, Director
Signature
Christina K. Byrom, attorney-in-fact for Ezra Y. Yacob
Issuer symbol
EOG
Transactions as of
10 Mar 2023
Net transactions value
-$671,238
Form type
4
Filing time
14 Mar 2023, 14:13:50 UTC
Previous filing
01 Mar 2023
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOG Common Stock Options Exercise $1,528,122 +15,870 +14% $96.29 126,039 10 Mar 2023 Direct
transaction EOG Common Stock Disposed to Issuer $1,528,204 -13,410 -11% $113.96 112,629 10 Mar 2023 Direct
transaction EOG Common Stock Tax liability $110,313 -968 -0.86% $113.96 111,661 10 Mar 2023 Direct
transaction EOG Common Stock Options Exercise $677,988 +9,029 +8.1% $75.09 120,690 10 Mar 2023 Direct
transaction EOG Common Stock Disposed to Issuer $678,062 -5,950 -4.9% $113.96 114,740 10 Mar 2023 Direct
transaction EOG Common Stock Tax liability $138,120 -1,212 -1.1% $113.96 113,528 10 Mar 2023 Direct
transaction EOG Common Stock Options Exercise $225,127 +6,013 +5.3% $37.44 119,541 10 Mar 2023 Direct
transaction EOG Common Stock Disposed to Issuer $225,185 -1,976 -1.7% $113.96 117,565 10 Mar 2023 Direct
transaction EOG Common Stock Tax liability $181,082 -1,589 -1.4% $113.96 115,976 10 Mar 2023 Direct
transaction EOG Common Stock Options Exercise $159,053 +3,190 +2.8% $49.86 119,166 10 Mar 2023 Direct
transaction EOG Common Stock Disposed to Issuer $159,088 -1,396 -1.2% $113.96 117,770 10 Mar 2023 Direct
transaction EOG Common Stock Tax liability $80,456 -706 -0.6% $113.96 117,064 10 Mar 2023 Direct
transaction EOG Common Stock Options Exercise $1,041,032 +12,725 +11% $81.81 129,789 10 Mar 2023 Direct
transaction EOG Common Stock Disposed to Issuer $1,041,139 -9,136 -7% $113.96 120,653 10 Mar 2023 Direct
transaction EOG Common Stock Tax liability $160,912 -1,412 -1.2% $113.96 119,241 10 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOG Stock Appreciation Rights Options Exercise $0 -15,870 -100% $0.000000* 0 10 Mar 2023 Common Stock 15,870 $96.29 Direct F1
transaction EOG Stock Appreciation Rights Options Exercise $0 -9,029 -100% $0.000000* 0 10 Mar 2023 Common Stock 9,029 $75.09 Direct F2
transaction EOG Stock Appreciation Rights Options Exercise $0 -6,013 -67% $0.000000 3,016 10 Mar 2023 Common Stock 6,013 $37.44 Direct F3
transaction EOG Stock Appreciation Rights Options Exercise $0 -3,190 -67% $0.000000 1,600 10 Mar 2023 Common Stock 3,190 $49.86 Direct F4
transaction EOG Stock Appreciation Rights Options Exercise $0 -12,725 -33% $0.000000 25,489 10 Mar 2023 Common Stock 12,725 $81.81 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F2 The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F3 The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F4 The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the January 4, 2021 date of grant. The SARs granted will become fully exercisable on January 4, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F5 The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.